PreveCeutical Medical Inc.
PREV
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.40% | 9.03% | -158.04% | -13.45% | 14.13% |
| Total Depreciation and Amortization | 5.48% | 2.78% | -27.45% | -20.65% | -12.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.89% | -11.90% | 427.79% | -41.17% | -42.23% |
| Change in Net Operating Assets | 35.22% | -35.40% | 42.48% | 23.44% | -15.32% |
| Cash from Operations | -76.68% | -41.44% | -1,071.89% | -904.08% | -199.22% |
| Capital Expenditure | -16.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,766.67% | -- | -- | -- | 200.00% |
| Cash from Investing | -2,361.11% | -- | -- | -- | 175.00% |
| Total Debt Issued | 26.24% | 9.77% | -21.61% | -12.68% | -9.34% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 104.72% | 63.16% | 12.10% | -4.00% | 6.55% |
| Foreign Exchange rate Adjustments | -- | -83.33% | 99.49% | 99.14% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 212.00% | 1,387.50% | -57.14% | -750.00% | -225.00% |